文献速递糖尿病

1型糖尿病患者发生阻塞性睡眠呼吸暂停的风险:一项基于人群的回顾性队列研究

Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study.
PubMed 文献 · Diabetologia · 2022-05-24

该研究利用英国初级保健数据库THIN,在1995年1月至2018年1月间开展回顾性队列研究,比较1型糖尿病患者与按年龄、性别、BMI和全科诊所匹配的无1型糖尿病患者的阻塞性睡眠呼吸暂停发病率。共纳入34,147例暴露者和129,500例匹配非暴露者,中位随访5.43年,调整后HR为1.53(95%CI 1.25, 1.86;p<0.001)。

要点

  • 1型糖尿病患者发生阻塞性睡眠呼吸暂停的风险较无1型糖尿病者升高,调整后HR为1.53(95%CI 1.25, 1.86;p<0.001)。
  • 1型糖尿病患者的阻塞性睡眠呼吸暂停预测因素包括年龄较大、男性、肥胖、使用降压或降脂药物、心房颤动和抑郁。
  • 作者建议临床医生对年老、肥胖、男性、有心房颤动或抑郁、或正在使用降脂或降压药物的1型糖尿病患者怀疑阻塞性睡眠呼吸暂停。

核心结论

  • 与无糖尿病患者相比,1型糖尿病患者发生阻塞性睡眠呼吸暂停的风险增加。

研究设计与样本

  • 利用英国初级保健数据库THIN,在1995年1月至2018年1月间开展回顾性队列研究,比较1型糖尿病患者(暴露)与按年龄、性别、BMI和全科诊所匹配的无1型糖尿病者(非暴露)的阻塞性睡眠呼吸暂停发病率。
  • 共纳入34,147例暴露者和129,500例匹配非暴露者;中位随访时间为5.43年(IQR 2.19-10.11),平均BMI为25.82 kg/m2(SD 4.33)。
  • 采用Cox比例风险回归模型估算未调整和调整风险比,基于完整病例分析。

主要发现

  • 1型糖尿病患者发生阻塞性睡眠呼吸暂停的调整HR为1.53(95%CI 1.25, 1.86;p<0.001),对照组为无1型糖尿病者。
  • 1型糖尿病患者中发生阻塞性睡眠呼吸暂停的预测因素包括年龄较大、男性、肥胖、被处方降压或降脂药物、心房颤动和抑郁。

临床怎么用

  • 作者建议临床医生对年老、肥胖、男性、有心房颤动或抑郁、或正在使用降脂或降压药物的1型糖尿病患者怀疑阻塞性睡眠呼吸暂停。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: People with type 2 diabetes are at increased risk of developing obstructive sleep apnoea. However, it is not known whether people with type 1 diabetes are also at an increased risk of obstructive sleep apnoea. This study aimed to examine whether people with type 1 diabetes are at increased risk of incident obstructive sleep apnoea compared with a matched cohort without type 1 diabetes. METHODS: We used a UK primary care database, The Health Improvement Network (THIN), to perform a retrospective cohort study between January 1995 and January 2018 comparing sleep apnoea incidence between patients with type 1 diabetes (exposed) and without type 1 diabetes (unexposed) (matched for age, sex, BMI and general practice). The outcome was incidence of obstructive sleep apnoea. Baseline covariates and characteristics were assessed at the start of the study based on the most recent value recorded prior to the index date. The Cox proportional hazards regression model was used to estimate unadjusted and adjusted hazard ratios, based on a complete-case analysis. RESULTS: In total, 34,147 exposed and 129,500 matched unexposed patients were included. The median follow-up time was 5.43 years ((IQR 2.19-10.11), and the mean BMI was 25.82 kg/m2 (SD 4.33). The adjusted HR for incident obstructive sleep apnoea in patients with type 1 diabetes vs those without type 1 diabetes was 1.53 (95% CI 1.25, 1.86; p<0.001). Predictors of incident obstructive sleep apnoea in patients with type 1 diabetes were older age, male sex, obesity, being prescribed antihypertensive or lipid-lowering drugs, atrial fibrillation and depression. CONCLUSIONS/INTERPRETATION: Individuals with type 1 diabetes are at increased risk of obstructive sleep apnoea compared with people without diabetes. Clinicians should suspect obstructive sleep apnoea in patients with type 1 diabetes if they are old, have obesity, are male, have atrial fibrillation or depression, or if they are taking lipid-lowering or antihypertensive drugs.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Alshehri Z, Subramanian A, Adderley NJ, et al. Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study. Diabetologia. 2022. PMID: 35608616. doi:10.1007/s00125-022-05714-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。